These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31635831)

  • 41. [Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].
    Ben Yahia M; Mavier P; Métreau JM; Zafrani ES; Fabre M; Gatineau-Saillant G; Dhumeaux D; Mallat A
    Gastroenterol Clin Biol; 1993; 17(12):959-62. PubMed ID: 8125230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of mefenamic acid sustained release beads based on kappa-carrageenan.
    Ozsoy Y; Bergişadi N
    Boll Chim Farm; 2000; 139(3):120-3. PubMed ID: 10961021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions].
    Teschke R; Schulze J
    Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fatal hepatoxicity secondary to nimesulide.
    Merlani G; Fox M; Oehen HP; Cathomas G; Renner EL; Fattinger K; Schneemann M; Kullak-Ublick GA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):321-6. PubMed ID: 11549211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of mefenamic acid on the osmotic fragility of lacertilian erythrocytes.
    Ahmad M; Hasan R; Qureshi A; Ahmad M; Ahmed Z
    Pak J Pharm Sci; 2005 Apr; 18(2):14-8. PubMed ID: 16431392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatitis due to pirprofen; 3 cases, 1 fatality].
    Fouin-Fortunet H; Lerebours E; Bernet J; Hemet J; Colin R
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):23-5. PubMed ID: 2938537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bendazac hepatotoxicity: analysis of 16 cases].
    Prieto de Paula JM; Rodríguez Rodríguez E; Villamandos Nicás V; Sanz de la Fuente H; Prada Mínguez A; del Portillo Rubí A
    Rev Clin Esp; 1995 Jun; 195(6):387-9. PubMed ID: 7644786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and pathological overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel.
    de Sanctis S; Qureshi T; Stebbing JF
    Am J Surg Pathol; 2001 Apr; 25(4):539-41. PubMed ID: 11257631
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparison of tiaprofenic acid, mefenamic acid and placebo in the treatment of dysmenorrhoea in general practice.
    Tilyard MW; Dovey SM
    Aust N Z J Obstet Gynaecol; 1992 May; 32(2):165-8. PubMed ID: 1520205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mefenamic acid nephropathy.
    Robertson CE; Ford MJ; Van Someren V; Dlugolecka M; Prescott LF
    Lancet; 1980 Aug; 2(8188):232-3. PubMed ID: 6105396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis.
    Lago EM; Silva MP; Queiroz TG; Mazloum SF; Rodrigues VC; Carnaúba PU; Pinto PL; Rocha JA; Ferreira LLG; Andricopulo AD; de Moraes J
    EBioMedicine; 2019 May; 43():370-379. PubMed ID: 31027918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fever, pneumonia and eosinophilia].
    Berger D; Pichler W; Savic S; Schoenenberger R; Borer H
    Praxis (Bern 1994); 2007 Oct; 96(40):1543-7. PubMed ID: 17966825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing capping and cracking of mefenamic acid tablets.
    Adam A; Schrimpl L; Schmidt PC
    Drug Dev Ind Pharm; 2000 May; 26(5):489-97. PubMed ID: 10789060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
    Nor Azlin MI; Maryasalwati I; Norzilawati MN; Mahdy ZA; Jamil MA; Zainul Rashid MR
    J Obstet Gynaecol; 2008 May; 28(4):424-6. PubMed ID: 18604680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Making a diagnosis of herbal-related toxic hepatitis.
    Haller CA; Dyer JE; Ko R; Olson KR
    West J Med; 2002 Jan; 176(1):39-44. PubMed ID: 11788538
    [No Abstract]   [Full Text] [Related]  

  • 56. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
    Teschke R; Schmidt-Taenzer W; Wolff A
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An anti-inflammatory drug (mefenamic acid) incorporated in biodegradable alginate beads: development and optimization of the process using factorial design.
    Sevgi F; Kaynarsoy B; Ertan G
    Pharm Dev Technol; 2008; 13(1):5-13. PubMed ID: 18300095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Liver toxicity of drugs of plant origin].
    Stickel F; Seitz HK; Hahn EG; Schuppan D
    Z Gastroenterol; 2001 Mar; 39(3):225-32, 234-7. PubMed ID: 11324140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
    Zaragoza Marcet A; Alfonso Moreno V; Roig Catalá E
    Rev Esp Enferm Dig; 1995 Jun; 87(6):472-5. PubMed ID: 7612373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation.
    Panis B; Wong DR; Hooymans PM; De Smet PA; Rosias PP
    J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):256-8. PubMed ID: 16056110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.